Recombinant multi-species CHST15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHST15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Chondroitin sulfate (CS) is a glycosaminoglycan which is an important structural component of the extracellular matrix and which links to proteins to form proteoglycans. Chondroitin sulfate E (CS-E) is an isomer of chondroitin sulfate in which the C-4 and C-6 hydroxyl groups are sulfated. This gene encodes a type II transmembrane glycoprotein that acts as a sulfotransferase to transfer sulfate to the C-6 hydroxal group of chondroitin sulfate. This gene has also been identified as being co-expressed with RAG1 in B-cells and as potentially acting as a B-cell surface signaling receptor. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2012]
The Alternative Names of target: 4631426J05Rik,B-cell RAG-associated gene protein (hBRAG),BRAG,CHST15,Carbohydrate sulfotransferase 15,Chst15,GALNAC4S-6ST,GalNAc4S-6ST,GalNAc4S6ST,GalNAcS-6ST,Galnac4s-6st,MAd5,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST),mKIAA0598

Target products collectionGo to CHST15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0199-Ag-1/ GM-Tg-hg-IP0199-Ag-2 Human CHST15 protein Human
GM-Tg-rg-IP0199-Ag-1/ GM-Tg-rg-IP0199-Ag-2 Rat CHST15 protein Rat
GM-Tg-mg-IP0199-Ag-1/ GM-Tg-mg-IP0199-Ag-2 Mouse CHST15 protein Mouse
GM-Tg-cynog-IP0199-Ag-1/ GM-Tg-cynog-IP0199-Ag-2 Cynomolgus/Rhesus macaque CHST15 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0199-Ag-1/ GM-Tg-felg-IP0199-Ag-2 Feline CHST15 protein Feline
GM-Tg-cang-IP0199-Ag-1/ GM-Tg-cang-IP0199-Ag-2 Canine CHST15 protein Canine
GM-Tg-bovg-IP0199-Ag-1/ GM-Tg-bovg-IP0199-Ag-2 Bovine CHST15 protein Bovine
GM-Tg-equg-IP0199-Ag-1/ GM-Tg-equg-IP0199-Ag-2 Equine CHST15 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0199-Ag-1/ GM-Tg-hg-IP0199-Ag-2; GM-Tg-rg-IP0199-Ag-1/ GM-Tg-rg-IP0199-Ag-2;
GM-Tg-mg-IP0199-Ag-1/ GM-Tg-mg-IP0199-Ag-2; GM-Tg-cynog-IP0199-Ag-1/ GM-Tg-cynog-IP0199-Ag-2;
GM-Tg-felg-IP0199-Ag-1/ GM-Tg-felg-IP0199-Ag-2; GM-Tg-cang-IP0199-Ag-1/ GM-Tg-cang-IP0199-Ag-2;
GM-Tg-bovg-IP0199-Ag-1/ GM-Tg-bovg-IP0199-Ag-2; GM-Tg-equg-IP0199-Ag-1/ GM-Tg-equg-IP0199-Ag-2
Products Name CHST15 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CHST15
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHST15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.